1. 21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab. (17th December 2018) Authors: Awada, G; Özdemir, I; Schwarze, J K; Daeninck, E; Gondry, O; Jansen, Y; Seremet, T; Keyaerts, M; Everaert, H; Neyns, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P06.05.A Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial. (5th September 2022) Authors: Geens, W; Schwarze, J K; Awada, G; Tijtgat, J; Lescrauwet, L; Geeraerts, X; Vaeyens, F; Cras, L; Van Binst, A; Everaert, H; Michotte, A; Cauwenbergh, T; Bruneau, M; Forsyth, R; Tuyaerts, S; Neyns, B; Duerinck, J Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗